Highlights from the Transcatheter Cardiovascular Therapeutics 2021 meeting
Quynh Nguyen
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Search for more papers by this authorJessica G. Y. Luc
Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
Search for more papers by this authorCorresponding Author
Peter L. Skarsgard
Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
Correspondence
Peter L. Skarsgard, Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Email: [email protected]
Search for more papers by this authorQuynh Nguyen
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Search for more papers by this authorJessica G. Y. Luc
Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
Search for more papers by this authorCorresponding Author
Peter L. Skarsgard
Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
Correspondence
Peter L. Skarsgard, Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Email: [email protected]
Search for more papers by this author
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest with the contents of this article.
REFERENCES
- 1Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52: 1584–8.
- 2Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017; 69: 278–87.
- 3Rios SA, Bravo CA, Weinreich M, Olmedo W, Villablanca P, Villela MA, et al. Meta-analysis and trial sequential analysis comparing percutaneous ventricular assist devices versus intra-aortic balloon pump during high-risk percutaneous coronary intervention or cardiogenic shock. Am J Cardiol. 2018; 122: 1330–8.
- 4Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019; 139: 1249–58.
- 5Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation. 2020; 142: 2095–106.
- 6Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, et al.; STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009; 360: 1705–17.
- 7Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011; 377: 658–66.
- 8Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016; 387: 453–61.
- 9Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail. 2014; 7: 935–44.
- 10Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 2016; 4: 333–44.
- 11Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021; 398: 991–1001.
- 12Zile MR, Lindenfeld J, Weaver FA, Zannad F, Galle E, Rogers T, et al. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol. 2020; 76: 1–13.
